The Property Masters Guild (PMG) announced the winners of the inaugural PMG MacGuffin Awards, which is the only awards show to date celebrating the significant artistic achievements of Property ...

Some treatments and procedures become routine despite lacking strong evidence to show that they’re beneficial. Recent studies have called a few into question. By Paula Span An older patient with ...

Now, a team of UBC Okanagan researchers believe they have found a way to harness the strengths of both technologies in a way that could be life-changing-;and life-saving-;for many. Dr. Hadi ...

In his doctoral dissertation completed at the University of Jyväskylä, Finland, Tero Sievänen demonstrates that the cancer risk of Lynch syndrome carriers can be assessed based on circulating ...

Saint Louis University's School of Medicine has a long tradition of excellence in medical school, graduate medical education and graduate education. Established in 1836, the school has the distinction ...

Multidisciplinary research, such as a study of heart disease during and after cancer therapy, is a key strategy for advancement of cancer survivorship care. Beyond Cancer: Confronting the ...

Repeat expansions in the FGF14 gene can cause late-onset cerebellar ataxia (SCA27B), however the defining features of pathogenic expansions remain uncertain. Here, the authors compare the sequence ...

Here's how to watch the 2025 Hartford Wolf Pack vs Providence Bruins on FloHockey. The 2025 Hartford Wolf Pack vs Providence Bruins starts on Mar 29, 2025. How to Live Stream 2025 Hartford Wolf Pack ...

Here's how to watch the 2025 Providence Bruins vs Springfield Thunderbirds on FloHockey. The 2025 Providence Bruins vs Springfield Thunderbirds starts on Mar 16, 2025. How to Live Stream 2025 ...

PROVIDENCE, R.I. (WLNE) — Ahead of a public meeting on Providence’s next master plan, advocates are calling on city leaders to consider bolder changes. The Providence Streets Coalition ...

Drs Kathy D. Miller and Heather A. Parsons explore the complexities and evolving strategies in managing HER2+ oligometastatic breast cancer.